Download PDF
CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2012; 33(03): 189
DOI: 10.4103/0971-5851.103154
LETTERS TO EDITOR

Hemolytic uremic syndrome and E. coli infection in cancerous patients: A topic to be discussed in oncology

Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok, Thailand 10160; Visiting University Professor, Hainan Medical University, Hainan, China
› Author Affiliations
› Further Information
Also available at
  PDF Download Permissions and Reprints


Publication History

Article published online:
02 August 2021

© 2012. Indian Society of Medical and Paediatric Oncology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Alexandrescu DT, Maddukuri P, Wiernik PH, Dutcher JP. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanoma. J Immunother 2005;28:144-7.
  • 2 Ravandi-Kashani F, Cortes J, Talpaz M, Kantarjian HM. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect? Cancer 1999;85:2583-8.
  • 3 Pirrotta MT, Bucalossi A. Thrombotic microangiopathy and occult neoplasia. Cardiovasc Hematol Disord Drug Targets 2010;10:87-93.